Compounds of Formula I ##STR1## are disclosed as inhibitors having {TAIL ~ activity} against the aspartyl proteases, plasmepsin and cathepsin D. The compounds are therefore useful for treatment of diseases such as malaria and {HEAD ~ Alzheimers disease} 
Compounds of Formula I # # STR1 # # are disclosed as inhibitors having { TAIL ~ activity } against the aspartyl proteases , plasmepsin and cathepsin D. The compounds are therefore useful for treatment of diseases such as malaria and { HEAD ~ Alzheimers disease }
OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD